Expression of miR-126 and its potential function in coronary artery disease

Xiaoyan Wang1, Yajun Lian2, Xin Wen3

  • 1Department of Ultrasound, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, Shanxi, China.

African Health Sciences
|October 25, 2017
PubMed

Insights

MicroRNA-126 (miR-126) is down-regulated in coronary artery disease (CAD) patients. Lower miR-126 levels may indicate CAD, suggesting its potential as a novel biomarker for the condition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) poses a significant global health burden.
  • Identifying reliable biomarkers for early detection and management of CAD is crucial.
  • MicroRNAs (miRNAs) are emerging as key regulators in cardiovascular pathophysiology.

Purpose of the Study:

  • To investigate the expression levels of miR-126 in patients with coronary artery disease (CAD).
  • To explore the potential role of miR-126 and its targets in the development of atherosclerosis.
  • To assess the association between miR-126 and clinical indicators in CAD.

Main Methods:

  • Real-time quantitative PCR was employed to measure plasma miR-126 levels in 60 CAD patients and 25 healthy controls.
  • Enzyme-linked immunosorbent assay (ELISA) was used to quantify plasma levels of placenta growth factor (PLGF).
  • CAD patients were stratified into stable angina pectoris (SAP), unstable angina pectoris (UAP), and acute myocardial infarction (AMI) groups.

Main Results:

  • Plasma miR-126 expression was significantly lower in CAD patients compared to healthy controls (P<0.01).
  • Plasma PLGF levels were significantly elevated in patients with UAP and AMI compared to controls (P<0.01).
  • A significant inverse association was observed between miR-126 expression and PLGF levels in patients with AMI.

Conclusions:

  • miR-126 may serve as a novel and valuable biomarker for the diagnosis of coronary artery disease.
  • The down-regulation of miR-126 in CAD suggests its involvement in the atherosclerotic process.
  • Further research is warranted to elucidate the precise mechanisms underlying miR-126's role in CAD.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
646
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
437
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
460